What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

UniSA Professor Richard D'Andrea and Associate Professor Lisa Ebert in the new lab.A new tissue culture facility has opened at UniSA today, helping to ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

A retrospective analysis showed improved overall survival (OS) with Orca-T compared with post-transplant cyclophosphamide in ...